Article
MUC5B and Idiopathic Pulmonary Fibrosis.
Annals of the American Thoracic Society - 1 Nov 2015
Yang Ivana V, Fingerlin Tasha E, Evans Christopher M, Schwarz Marvin I, Schwartz David A
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF), a fatal disease that is a result of complex interactions between genetics and the environment, has limited treatment options. We have identified the MUC5B promoter polymorphism and other common genetic variants that in aggregate explain roughly one-third of disease risk. The MUC5B promoter polymorphism is the strongest and the most replicated genetic risk factor for IPF,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
